Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARomatherapy for Cognitive Trajectory in Chinese After Percutaneous Coronary Intervention (ARCTIC-PCI): a Randomized, Double-blind, Placebo-controlled Trial

NCT04103086 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT04103086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04103086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARomatherapy for Cognitive Trajectory in Chinese After Percutaneous Coronary Intervention (ARCTIC-PCI): a Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2019
Completion date
June 30, 2021
Enrollment
660 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention